Robert R Redfield's most recent trade in Traws Pharma Inc. was a trade of 65,676 Stock Option (right to purchase) done . Disclosure was reported to the exchange on Dec. 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Traws Pharma Inc | Robert R Redfield | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 65,676 | 65,676 | - | - | Stock Option (right to purchase) | |
| Traws Pharma Inc | Robert R Redfield | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 16,419 | 113,919 (0%) | 0% | 0 | Common Stock | |
| Traws Pharma Inc | Robert R Redfield | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2025 | 32,406 | 32,406 | - | - | Stock Option (right to purchase) | |
| Traws Pharma Inc | Robert Redfield | Acting Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 97,500 | 97,500 (0%) | 0% | - | Common Stock |